Davenport & CO LLC Charles River Laboratories International, Inc. Transaction History
Davenport & CO LLC
- $16 Billion
- Q2 2024
A detailed history of Davenport & CO LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 18,489 shares of CRL stock, worth $3.67 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,489
Previous 12,907
43.25%
Holding current value
$3.67 Million
Previous $3.5 Million
9.21%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$415 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$379 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$272 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...